Antibody-mediated rejection

Current Opinion in Organ Transplantation

Volumn 17, Issue 5, 2012, Pages 551-557

  Kittleson, Michelle M ^a   Kobashigawa, Jon A ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

antibody mediated rejection; heart transplantation; sensitization

Indexed keywords

BORTEZOMIB; CORTICOSTEROID; CYCLOSPORIN; HEPARIN; HLA ANTIBODY; HLA ANTIGEN; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ANTIBODY DETECTION; ANTIBODY MEDIATED REJECTION; ANTIBODY PRODUCTION; ANTIGEN DETECTION; CARDIAC GRAFT REJECTION; CARDIOGENIC SHOCK; CORONARY ARTERY DISEASE; DRUG SUBSTITUTION; EXTRACORPOREAL OXYGENATION; HEART EJECTION FRACTION; HEART FAILURE; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; NONHUMAN; PLASMAPHERESIS; PROGNOSIS; PUVA; RECURRENT DISEASE; REOPERATION; REVIEW; RISK FACTOR; STANDARDIZATION; SYMPTOM; T LYMPHOCYTE; TREATMENT INDICATION; TREATMENT OUTCOME;

ANTIBODIES; GRAFT REJECTION; HLA ANTIGENS; HUMANS; ORGAN TRANSPLANTATION; TRANSPLANTATION IMMUNOLOGY;

EID: 84866353074     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e3283577fef     Document Type: Review

References (26)

1. Costanzo MR, Costanzo MR, Dipchand A, et al. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant 2010; 29:914-956.
2. Stehlik J, Edwards LB, Kucheryavaya AY, et al. The registry of the International Society for Heart and Lung Transplantation: twenty-eighth Adult Heart Transplant Report 2011. J Heart Lung Transplant 2011; 30:1078-1094.
3. Kobashigawa J, Mehra M, West L, et al. Report from a consensus conference on the sensitized patient awaiting heart transplantation. J Heart Lung Transplant 2009; 28:213-225.
4. Kobashigawa J, Crespo-Leiro MG, Ensminger SM, et al. Report from a consensus conference on antibody-mediated rejection in heart transplantation. J Heart Lung Transplant 2011; 30:252-269.
5. Nwakanma LU, Williams JA, Weiss ES, et al. Influence of Pretransplant panelreactive antibody on outcomes in 8,160 heart transplant recipients in recent era. Ann Thorac Surg 2007; 84:1556-1563. (Pubitemid 47588132)
6. Sutherland SM, Chen G, Sequeira FA, et al. Complement-fixing donorspecific antibodies identified by a novel C1q assay are associated with allograft loss. Pediatr Transplant 2012; 16:12-17.
7. Stehlik J, Islam N, Hurst D, et al. Utility of virtual crossmatch in sensitized patients awaiting heart transplantation. The J Heart Lung Transplant 2009; 28:1129-1134.
8. Cecka JM. Calculated PRA (CPRA): the new measure of sensitization for transplant candidates. Am J Transplant 2010; 10:26-29.
9. Vo AA, Lukovsky M, Toyoda M, et al. Rituximab and intravenous immune globulin for desensitization during renal transplantation. N Engl J Med 2008; 359:242-251. (Pubitemid 352008439)
10. Patel J, Everly M, Chang D, et al. Reduction of alloantibodies via proteosome inhibition in cardiac transplantation. J Heart Lung Transplant 2011; 30:1320-1326.
11. Berry GJ, Angelini A, Burke MM, et al. The ISHLT working formulation for pathologic diagnosis of antibody-mediated rejection in heart transplantation: Evolution and current status (2005-2011). J Heart Lung Transplant 2011; 30:601-611.
12. Wu GW, Kobashigawa JA, Fishbein MC, et al. Asymptomatic antibodymediated rejection after heart transplantation predicts poor outcomes. J Heart Lung Transplant 2009; 28:417-422.
13. Kfoury AG, Stehlik J, Renlund DG, et al. Impact of repetitive episodes of antibody-mediated or cellular rejection on cardiovascular mortality in cardiac transplant recipients: defining rejection patterns. J Heart Lung Transplant 2006; 25:1277-1282. (Pubitemid 44767730)
14. Kfoury AG, Hammond ME, Snow GL, et al. Cardiovascular mortality among heart transplant recipients with asymptomatic antibody-mediated or stable mixed cellular and antibody-mediated rejection. J Heart Lung Transplant 2009; 28:781-784.
15. Kobashigawa JA, Miller LW, Russell SD, et al. Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report. Am J Transplant 2006; 6:1377-1386. (Pubitemid 44030320)
16. Kobashigawa JA, Patel J, Furukawa H, et al. Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients. J Heart Lung Transplant 2006; 25:434-439.
17. Keogh A, RichardsonM, Ruygrok P, et al. Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial. Circulation 2004; 110:2694-2700. (Pubitemid 39453021)
18. Eisen HJ, Tuzcu EM, Dorent R, et al. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med 2003; 349:847-858. (Pubitemid 37025404)
19. Mancini D, Pinney S, Burkhoff D, et al. Use of rapamycin slows progression of cardiac transplantation vasculopathy. Circulation 2003; 108:48-53. (Pubitemid 36859019)
20. Gaber AO, First MR, Tesi RJ, et al. Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation. Transplantation 1998; 66:29-37. (Pubitemid 28341164)
21. Arbustini E, Roberts WC. Morphological observations in the epicardial coronary arteries and their surroundings late after cardiac transplantation (allograft vascular disease). Am J Cardiol 1996; 78:814-820. (Pubitemid 126657153)
22. Fishbein MC, Kobashigawa J. Biopsy-negative cardiac transplant rejection: etiology, diagnosis, and therapy. Curr Opin Cardiol 2004; 19:166-169. (Pubitemid 38373133)
23. Kittleson MM, Patel JK, Moriguchi JD, et al. Heart transplant recipients supported with extracorporeal membrane oxygenation: Outcomes from a single-center experience. J Heart Lung Transplant 2011; 30:1250-1256.
24. Patel JK, Kittleson M, Kobashigawa JA. Cardiac allograft rejection. Surgeon 2011; 9:160-167.
25. Barr ML, Meiser BM, Eisen HJ, et al. Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group. N Engl J Med 1998; 339:1744-1751. (Pubitemid 28555433)
26. Kirklin JK, Brown RN, Huang ST, et al. Rejection with hemodynamic compromise: objective evidence for efficacy of photopheresis. J Heart Lung Transplant 2006; 25:283-288. (Pubitemid 43290657)